TipRanks
Go Ultimate55% OFF

Ekta Bagri Profile - Zacks Equity Research Blogger

4 Followers

Ekta Bagri's Stock Coverage

GILD
Gilead Sciences
Oct 15, 2026Neutral6Ratings67%-2.57%
BMY
Bristol-Myers Squibb
Oct 12, 2026Neutral7Ratings0%-4.45%
KROS
Keros Therapeutics
Oct 07, 2026Bullish1Ratings0%-1.50%
GERN
Geron
Oct 07, 2026Bullish1Ratings0%-25.50%
LQDA
Liquidia Technologies
Sep 30, 2026Bearish6Ratings60%-1.74%
ALKS
Alkermes
Sep 30, 2026Neutral1Ratings――
PFE
Pfizer
Sep 24, 2026Bullish1Ratings100%+7.40%
MRK
Merck & Company
Sep 24, 2026Bullish3Ratings67%+7.40%
UTHR
United Therapeutics
Sep 11, 2026Bearish4Ratings0%-13.80%
INSM
Insmed
Sep 11, 2026Bearish2Ratings100%+13.00%

Disclaimer: TipRanks collects ratings of bloggers by scanning publicly available reports on financial websites and by receiving reports directly from the bloggers or from our users. The information displayed might not be accurate or up to date. The displayed ratings are made entirely at the sole discretion of the bloggers. TipRanks holds no liability over the bloggers information or opinions expressed on the site. See how TipRanks ranks experts and calculates performance.